Asia must treat patents to treat patients

Listen to this article Trade-related intellectual property (IP) policies present significant barriers to affordable medicines, particularly in low- and middle-income countries (LMICs). Many LMICs — including least developed countries (LDCs) — in Asia face the challenge of balancing their economic and trade priorities with the need to ensure affordable medicines for their populations. Meeting this […]